Inventiva (IVA) FCF Margin (2019 - 2021)

Inventiva (IVA) posted quarterly FCF Margin of 18298.46% for Q2 2021, down 1344441.0% year-over-year from N/an in Q2 2020, and down 74.95% quarter-over-quarter from 10459.46% in Q1 2021.

Inventiva (IVA) FCF Margin (2019 - 2021) Analysis & Trends

Inventiva's FCF Margin history runs 3 years deep, the most recent figure standing at 18298.46% for Q2 2021.

  • In Q2 2021, FCF Margin fell 1344441.0% year-over-year to 18298.46%; the TTM figure through Jun 2021 stood at 5222.14% (changed N/A YoY), while the FY2025 annual figure was 1323.49%, down 73994.0% from the prior year.
  • FCF Margin for Q2 2021 stood at 18298.46%, down from 10459.46% in the prior quarter.
  • The five-year high for FCF Margin was 264.68% in Q4 2019, with the low at 18298.46% in Q2 2021.
  • The 3-year median for FCF Margin is 4484.5% (2020), against an average of 6653.26%.
  • The sharpest annual moves came in 2020 and 2021: FCF Margin slumped 166328 bps in 2020, then plunged 1344441 bps in 2021.
  • Inventiva's FCF Margin stood at 264.68% in 2019, then sank by 628 bps to 1927.96% in 2020, then plunged by 849 bps to 18298.46% in 2021.
  • Business Quant data shows IVA's FCF Margin at 18298.46% in Q2 2021, 10459.46% in Q1 2021, and 1927.96% in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 13.35%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 25.68%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -77,594.17%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 70.82%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 22.62%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -22.35%
10 Inventiva 888.89 Mn 888.89 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -18,298.46%
Mar 31, 2021 -10,459.46%
Dec 31, 2020 -1,927.96%
Jun 30, 2020 -4,854.05%
Mar 31, 2020 -4,114.94%
Dec 31, 2019 -264.68%